SION Q4 2024 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SIONSionna Therapeutics, Inc.

$2B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$18M

Net Income

-$16M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$186M

Total Liabilities

$349M

Stockholders' Equity

-$164M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$18M	-$13M	-44.0%
Net Income	-$16M	-$12M	-33.4%